Skip to main content
. 2018 May-Jun;15(5-6):13–16.

TABLE 2.

Studies of deutetrabenazine

STUDY PHASE STUDY DESIGN DURATION n DRUG DOSE
ARM-TD14 II, III Randomized, double-blind, parallel-group 12 weeks 117 12 mg/day titrated to 48mg/day maximum (mean dose 39mg/day)
AIM-TD15 III Randomized, double-blind, placebo-controlled 12 weeks 298 12mg/day, 24mg/day, or 36mg/day